affinity purified goat 529 anti human igm coating ab (Bethyl)
Bethyl is a verified supplier 
95
Structured Review
Bethyl
affinity purified goat 529 anti human igm coating ab
Affinity Purified Goat 529 Anti Human Igm Coating Ab, supplied by Bethyl, used in various techniques. Bioz Stars score: 95/100, based on 259 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/affinity+purified+goat+529+anti+human+igm+coating+ab/Human+IgM+Antibody/pm41077783-229-61-72
Average 95 stars, based on 259 article reviews
Affinity Purified Goat 529 Anti Human Igm Coating Ab, supplied by Bethyl, used in various techniques. Bioz Stars score: 95/100, based on 259 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/affinity+purified+goat+529+anti+human+igm+coating+ab/Human+IgM+Antibody/pm41077783-229-61-72
Average 95 stars, based on 259 article reviews
affinity purified goat 529 anti human igm coating ab - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: A rapid immunization and antibody redesign platform for discovering broadly neutralizing antibodies against non-immunized SARS-CoV-2 variant. Article Snippet: Please cite this article as: Hamamichi S, Uno N, Shimoya K, Fukushima T, Abe M, Watanabe A, Ito M, Wakasa Y, Yajima Y, Suzuki R, Miyazaki N, Kamiyama A, Uno K, Hiratsuka M, Moriwaki T, Tamura T, Kanai K, Abe S, Fukuhara T, Kageyama S, Su’etsugu M, Kazuki Y, Tomizuka K, A rapid immunization and antibody redesign platform for discovering broadly neutralizing antibodies against non-immunized SARS-CoV-2 variant, Molecular Therapy (2025), doi: https://doi.org/10.1016/j.ymthe.2025.10.020. 96 Well Plates:Article Title: A rapid immunization and antibody redesign platform for discovering broadly neutralizing antibodies against non-immunized SARS-CoV-2 variant. Article Snippet: Please cite this article as: Hamamichi S, Uno N, Shimoya K, Fukushima T, Abe M, Watanabe A, Ito M, Wakasa Y, Yajima Y, Suzuki R, Miyazaki N, Kamiyama A, Uno K, Hiratsuka M, Moriwaki T, Tamura T, Kanai K, Abe S, Fukuhara T, Kageyama S, Su’etsugu M, Kazuki Y, Tomizuka K, A rapid immunization and antibody redesign platform for discovering broadly neutralizing antibodies against non-immunized SARS-CoV-2 variant, Molecular Therapy (2025), doi: https://doi.org/10.1016/j.ymthe.2025.10.020. Affinity Purification:Article Title: A rapid immunization and antibody redesign platform for discovering broadly neutralizing antibodies against non-immunized SARS-CoV-2 variant. Article Snippet: Please cite this article as: Hamamichi S, Uno N, Shimoya K, Fukushima T, Abe M, Watanabe A, Ito M, Wakasa Y, Yajima Y, Suzuki R, Miyazaki N, Kamiyama A, Uno K, Hiratsuka M, Moriwaki T, Tamura T, Kanai K, Abe S, Fukuhara T, Kageyama S, Su’etsugu M, Kazuki Y, Tomizuka K, A rapid immunization and antibody redesign platform for discovering broadly neutralizing antibodies against non-immunized SARS-CoV-2 variant, Molecular Therapy (2025), doi: https://doi.org/10.1016/j.ymthe.2025.10.020. |